Cargando…
dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
Hepatocellular carcinoma (HCC), which is associated with an absence of obvious symptoms and poor prognosis, is the second leading cause of cancer death worldwide. Genome-wide molecular biology studies should provide biological insights into HCC development. Based on the importance of phosphorylation...
Autores principales: | Chu, Yen-Wei, Chien, Ching-Hsuan, Sung, Mei-I, Chen, Chi-Wei, Chen, Yu-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272086/ https://www.ncbi.nlm.nih.gov/pubmed/32497121 http://dx.doi.org/10.1371/journal.pone.0234084 |
Ejemplares similares
-
Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021) -
An Overview of Biomarkers and Molecular Signatures in HCC
por: Yim, Seon-Hee, et al.
Publicado: (2010) -
Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities
por: Kwee, Sandi, et al.
Publicado: (2022) -
Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC
por: Wang, Hsei-Wei, et al.
Publicado: (2013) -
Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC
por: Cho, Hyo Jung, et al.
Publicado: (2021)